EP0717736 - PHOSPHORUS DERIVATIVES TO TREAT AIDS [Right-click to bookmark this link] | |||
Former [1996/26] | POLAR-SUBSTITUTED HYDROCARBONS | ||
[2003/48] | Status | No opposition filed within time limit Status updated on 25.03.2005 Database last updated on 31.08.2024 | Most recent event Tooltip | 28.12.2007 | Lapse of the patent in a contracting state New state(s): PT | published on 30.01.2008 [2008/05] | Applicant(s) | For all designated states Narhex Limited 11th floor, 3A Chater Road Hong Kong / HK | [N/P] |
Former [1996/26] | For all designated states NARHEX LIMITED 11th floor, 3A Chater Road Hong Kong / HK | Inventor(s) | 01 /
GROBELNY, Damian 11 Longfield Court Watsonia North, VIC 3087 / AU | [1996/26] | Representative(s) | Ablewhite, Alan James, et al Marks & Clerk 90 Long Acre London WC2E 9RA / GB | [N/P] |
Former [2001/18] | Ablewhite, Alan James, et al MARKS & CLERK, 57/60 Lincoln's Inn Fields London WC2A 3LS / GB | ||
Former [1996/26] | Lord, Hilton David, et al MARKS & CLERK, 57-60 Lincoln's Inn Fields London WC2A 3LS / GB | Application number, filing date | 94926731.4 | 12.09.1994 | [1996/26] | WO1994AU00538 | Priority number, date | AU1993PM01161 | 10.09.1993 Original published format: AU PM116193 | AU1994PM06446 | 24.06.1994 Original published format: AU PM644694 | [1996/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9507269 | Date: | 16.03.1995 | Language: | EN | [1995/12] | Type: | A1 Application with search report | No.: | EP0717736 | Date: | 26.06.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.03.1995 takes the place of the publication of the European patent application. | [1996/26] | Type: | B1 Patent specification | No.: | EP0717736 | Date: | 19.05.2004 | Language: | EN | [2004/21] | Search report(s) | International search report - published on: | AU | 16.03.1995 | (Supplementary) European search report - dispatched on: | EP | 15.07.1996 | Classification | IPC: | C07D255/02, C07D487/04, C07F9/60, C07F9/6509, C07D213/40 | [1996/34] | CPC: |
C07D237/04 (EP);
C07D255/02 (EP,KR);
C07C243/18 (EP);
C07C243/28 (EP);
C07C243/32 (EP);
C07C243/34 (EP);
C07C251/80 (EP);
C07C255/13 (EP);
C07C255/24 (EP);
C07C271/20 (EP);
C07C271/22 (EP);
C07C281/02 (EP);
C07D207/14 (EP);
C07D207/416 (EP);
C07D209/48 (EP);
C07D211/28 (EP);
C07D211/58 (EP);
C07D211/72 (EP);
C07D213/30 (EP);
C07D213/40 (EP);
C07D213/56 (EP);
C07D213/75 (EP);
C07D213/80 (EP);
C07D215/14 (EP);
C07D231/04 (EP);
C07D231/12 (EP);
C07D231/54 (EP);
C07D233/56 (EP);
C07D237/30 (EP);
C07D237/32 (EP);
C07D239/04 (EP);
C07D243/10 (EP);
C07D245/02 (EP);
C07D249/08 (EP);
C07D257/04 (EP);
C07D265/06 (EP);
C07D265/30 (EP);
C07D295/13 (EP);
C07D295/26 (EP);
C07D303/36 (EP);
C07D307/12 (EP);
C07D401/06 (EP);
C07D401/12 (EP);
C07D401/14 (EP);
C07D403/12 (EP);
C07D405/06 (EP);
C07D405/12 (EP);
C07D405/14 (EP);
C07D471/04 (EP);
C07D471/08 (EP);
C07D487/04 (EP,KR);
C07D487/08 (EP);
C07D491/04 (EP);
C07D495/04 (EP);
C07F9/091 (EP);
C07F9/093 (EP);
C07F9/1411 (EP);
C07F9/1412 (EP);
C07F9/5532 (EP);
C07F9/572 (EP);
C07F9/58 (EP);
C07F9/60 (EP);
C07F9/62 (EP);
C07F9/6506 (EP);
C07F9/650994 (EP);
C07F9/65583 (EP);
C07F9/65586 (EP);
C07F9/6561 (EP);
C07F9/65742 (EP);
C07F9/65744 (EP);
C07K5/06139 (EP);
C07K5/06191 (EP);
A61K38/00 (EP);
C07C2601/14 (EP);
C07C2601/16 (EP);
|
Former IPC [1996/26] | C07D255/02, C07D487/04, C07F9/60, C07F9/6509 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/26] | Title | German: | PHOSPHORDERIVATE ZUR BEHANDLUNG VON AIDS | [2003/48] | English: | PHOSPHORUS DERIVATIVES TO TREAT AIDS | [2003/48] | French: | DERIVES PHOSPHORES POUR TRAITER LE SIDA | [2003/48] |
Former [1996/26] | POLAR-SUBSTITUIERTE KOHLENWASSERSTOFFE | ||
Former [1996/26] | POLAR-SUBSTITUTED HYDROCARBONS | ||
Former [1996/26] | HYDROCARBURES A SUBSTITUANTS POLAIRES | Entry into regional phase | 07.03.1996 | National basic fee paid | 07.03.1996 | Search fee paid | 07.03.1996 | Designation fee(s) paid | 07.03.1996 | Examination fee paid | Examination procedure | 10.04.1995 | Request for preliminary examination filed International Preliminary Examining Authority: AU | 07.03.1996 | Examination requested [1996/26] | 14.12.1998 | Despatch of a communication from the examining division (Time limit: M06) | 18.06.1999 | Reply to a communication from the examining division | 11.05.2000 | Despatch of a communication from the examining division (Time limit: M06) | 21.02.2001 | Reply to a communication from the examining division | 24.04.2002 | Despatch of a communication from the examining division (Time limit: M06) | 09.12.2002 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 18.02.2003 | Reply to a communication from the examining division | 20.03.2003 | Despatch of a communication from the examining division (Time limit: M06) | 24.09.2003 | Reply to a communication from the examining division | 10.11.2003 | Communication of intention to grant the patent | 11.03.2004 | Fee for grant paid | 11.03.2004 | Fee for publishing/printing paid | Opposition(s) | 22.02.2005 | No opposition filed within time limit [2005/19] | Request for further processing for: | 18.02.2003 | Request for further processing filed | 18.02.2003 | Full payment received (date of receipt of payment) Request granted | 04.03.2003 | Decision despatched | 20.02.2001 | Request for further processing filed | 20.02.2001 | Full payment received (date of receipt of payment) Request granted | 29.03.2001 | Decision despatched | Fees paid | Renewal fee | 12.09.1996 | Renewal fee patent year 03 | 10.09.1997 | Renewal fee patent year 04 | 09.09.1998 | Renewal fee patent year 05 | 09.03.2000 | Renewal fee patent year 06 | 08.03.2001 | Renewal fee patent year 07 | 11.03.2002 | Renewal fee patent year 08 | 12.09.2002 | Renewal fee patent year 09 | 12.03.2004 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 30.09.1999 | 06   M06   Fee paid on   09.03.2000 | 30.09.2000 | 07   M06   Fee paid on   08.03.2001 | 30.09.2001 | 08   M06   Fee paid on   11.03.2002 | 30.09.2003 | 10   M06   Fee paid on   12.03.2004 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 19.05.2004 | ES | 19.05.2004 | DK | 19.08.2004 | GR | 19.08.2004 | SE | 19.08.2004 | LU | 12.09.2004 | MC | 30.09.2004 | PT | 19.10.2004 | [2008/05] |
Former [2007/16] | AT | 19.05.2004 | |
ES | 19.05.2004 | ||
DK | 19.08.2004 | ||
GR | 19.08.2004 | ||
SE | 19.08.2004 | ||
LU | 12.09.2004 | ||
MC | 30.09.2004 | ||
Former [2005/22] | AT | 19.05.2004 | |
DK | 19.08.2004 | ||
GR | 19.08.2004 | ||
SE | 19.08.2004 | ||
MC | 30.09.2004 | ||
Former [2005/18] | AT | 19.05.2004 | |
DK | 19.08.2004 | ||
GR | 19.08.2004 | ||
SE | 19.08.2004 | ||
Former [2005/11] | AT | 19.05.2004 | |
GR | 19.08.2004 | ||
SE | 19.08.2004 | ||
Former [2005/06] | GR | 19.08.2004 | |
SE | 19.08.2004 | ||
Former [2004/52] | SE | 19.08.2004 | Documents cited: | Search | [X] - KONG-TECK CHONG ET AL., "Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, (19930820), vol. 36, no. 17, pages 2575 - 2577, XP002007120 [X] 1-7,20-23 * complete document * DOI: http://dx.doi.org/10.1021/jm00069a018 | International search | [X]AU3570089 (UPJOHN CO); | [X]AU4566589 (HOECHST AG); | [X]AU4611589 (HOECHST AG); | [X]AU4230889 (MOLECULAR THERAPEUTICS INC); | [X]WO9009191 (SCHRAMM WOLFGANG [DE], et al); | [X]AU5371690 (HOECHST AG); | [X]AU6322190 (HOECHST AG); | [X]AU6633490 (UPJOHN CO); | [X]WO9108221 (WISCONSIN ALUMNI RES FOUND [US], et al); | [X]EP0432595 (BAYER AG [DE]); | [X]WO9110442 (SMITHKLINE BEECHAM CORP [US]); | [X]AU7131991 (BIO MEGA/BOEHRINGER INGELHEIM RES INC); | [X]AU7132391 (BIO MEGA/BOEHRINGER INGELHEIM RES INC); | [X]AU7132091 (BIO MEGA/BOEHRINGER INGELHEIM RES INC); | [X]AU7732691 (CIBA GEIGY AG); | [X]AU8205491 (DU PONT MERCK PHARMA); | [X]AU8191091 (SMITHKLINE BEECHAM CORP); | [X]AU8231391 (SMITHKLINE BEECHAM CORP); | [X]AU8320691 (SMITHKLINE BEECHAM CORP); | [X]AU8740991 (UPJOHN CO); | [X]AU8587791 (MERCK PATENT GMBH); | [X]AU8759491 (UPJOHN CO); | [X]US5116835 (RUEGER WOLFGANG [DE], et al); | [X]AU8730991 (HOECHST AG); | [X]AU9053191 (MONSANTO CO); | [X]AU9085191 (MONSANTO CO); | [X]AU9092591 (MONSANTO CO); | [X]AU9125191 (MONSANTO CO); | [X]AU9133291 (MONSANTO CO); | [X]AU8890091 (JAPAN ENERGY CORP); | [X]AU9122391 (SMITHKLINE BEECHAM CORP); | [X]US5126326 (ANDERSON PAUL C [CA], et al); | [X]AU8994191 (AMERICAN CYANAMID CO); | [X]US5132400 (GAMMILL RONALD B [US], et al); | [X]AU1081292 (SANKYO CO); | [X]AU9179091 (AVENTIS INC); | [X]US5145951 (VOGES KLAUS-PETER [DE], et al); | [X]WO9215319 (SMITHKLINE BEECHAM CORP [US]); | [X]WO9221696 (STANFORD RES INST INT [US]); | [XP]EP0519433 (HOECHST AG [DE]); | [X]AU1835592 (HOECHST AG); | [X]AU1937392 (NOVARTIS AG); | [X]AU2194492 (SANDOZ LTD); | [X]AU2412992 ; | [X]EP0528242 (BAYER AG [DE]); | [X]AU2469092 (SCHERING CORP); | [X]AU2288992 (NOVARTIS AG); | [X]US5198426 (HAMBY JAMES M [US], et al); | [X]AU2642492 (SMITHKLINE BEECHAM CORP); | [X]US5212157 (ANDERSON PAUL C [CA], et al); | [X]US5215968 (NICKEL WOLF-ULRICH [DE], et al); | [X]AU3162893 (LABORATOIRES MAYOLY SPINDLER S A R L, et al); | [X]US5221665 (SKILES JERRY W [US]); | [X]US5221667 (KALTENBRONN JAMES S [US], et al); | [XP]AU3516593 (BIO MEGA/BOEHRINGER INGELHEIM RES INC); | [XP]AU3739193 (NARHEX LTD); | [XP]US5250563 (CHEN SHIEH-SHUNG T [US], et al); | [XP]AU3880893 (BIO MEGA/BOEHRINGER INGELHEIM RES INC); | [XP]AU3562193 (CIBA GEIGY AG); | [XP]AU3716093 (BAYER AG); | [XP]US5268361 (ALMQUIST RONALD G [US], et al); | [XP]EP0574135 (NIPPON MINING CO [JP]); | [XP]AU4123093 (HOFFMANN LA ROCHE); | [XP]AU4165993 (SQUIBB & SONS INC); | [XP]US5294720 (JADHAV PRABHAKAR K [US], et al); | [XP]US5296604 (HANKO RUDOLF H [US], et al); | [X]AU4493093 (BAYER AG); | [XP]AU4907293 (NOVARTIS AG); | [E]AU6207094 (HOECHST AG) | [X] - CHIMICA OGGI, May 1991, TOMASSELLI et al., "The complexities of AIDS: An assesment of the HIV protease as a therapeutic target", pages 6 to 27. | [X] - JOURNAL OF MEDICINAL CHEMISTRY, Volume 34, Number 8, August 1991, HUFF J R., "HIV Protease: A novel chemotherapeutic target for AIDS", pages 2305 to 2314. | [ ] - THE MERCK INDEX, 11th Edition, 1989, MERCK & CO. INC., (RAHWAY N J, USA), Monograph Number: 32, 36, 47, 423, 481, 1507, 1540, 1543, 1575, 1591, 1592, 1593, 1597, 2785, 3676, 3679, 3680, 3681, 3716, 3718, 3751, 3755, 5760, 5865, 5867, 5868, 5938, 6001, 6047, 7809, 7811, 7835, 7836, 7837, 7839, 7854, 7855, 9247, 9257, 9629. | [ ] - DICTIONARY OF ORGANIC COMPOUNDS, J. Buckingham, 5th Edition, Volumes One to Five, 1982, and First to Tenth Supplements, 1983-1992, CHAPMAN & HALL (NEW YORK, USA), DOC Numbers: A-00943, A-01166, A-02605, A-2609, B-03483, C-03037, E-00484, E-00497, E-00671, E-00792, E-00802, E-01150, H-01166, H-01411, H-03303, M-00319, |